Anthony Vere Hodge

Biography

Gender Male
Titles N/A
Birthdate 1943-12-27
Education Radley, Trinity Coll Dublin (BA), Worcester Coll Oxford (DPhil)
Publications Publications Integration of Pharmaceutical Discovery and Development: Case Studies (1998, contrib a chapter), Antiviral Agents vol 1 Encyclopedia of Virology (2008, contrib a chapter), General Mechanisms of Antiviral Resistance, Genetics and Evolution of Infectious Diseases (with Hugh J Field, ed Michel Tibayrenc, 2011, contrib a chapter), Antiviral Agents for Herpes Simplex Virus (with Hugh J Field, Advanced Pharmacology 2013, contrib a chapter); reviews: Telbivudine/Torcitabine - Current Opinion in Investigational Drugs (2004), Recent Developments in Anti-Herpesvirus Drugs (with Hugh J Field, 2013)
Recreations bell ringing, gardening, hill walking
Clubs N/A
Style Dr Anthony Vere Hodge
Career joined Beecham Pharmaceuticals (then SmithKline Beecham Pharmaceuticals, now GlaxoSmithKline) 1969, worked on Interferon Inducers then Human Interferon (project mangr 1974-76), transferred to Antiviral Chemotherapy Project (which discovered Penciclovir 1983, and Famiclovir 1985); princ author of first publication with named antiherpesvirus compounds Famciclovir and Penciclovir (1989) and other articles on subject; seconded to Worldwide Strategic Product Devpt SmithKline Beecham 1993, assoc dir Anti-infectives Section 1995-96; dir Vere Hodge Antivirals Ltd 1996-, conslt Pharmasset Inc 2000-05; reviews ed Antiviral Chemistry and Chemotherapy (AVCC) 2005-08; memb: The Chromotographic Soc 1989, Int Soc for Antiviral Research 1990 (memb Pubn Ctee 2006-, hon sec 2008-14, chair 2014-), American Soc for Microbiology 1997; MRSC 1968
Food and drink etiquette

Food and drink etiquette

Debrett's notebooks

Debrett's notebooks

FOLLOW US ON TWITTER

FOLLOW US ON TWITTER